Q903J0 (Q903J0_HV1) Human immunodeficiency virus type 1 (HIV-1)
Protease UniProtKBInterProInteractive Modelling
99 aa; Sequence (Fasta) ;
14 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
20 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal Structure of HIV-1 Protease (Q7K) in Complex with Lopinavir |
Heteromer P03367; Q5RZ08; | 98.99 | 4×CL; 1×AB1; 2×GOL; | |||
| Crystal Structure of HIV-1 Protease (Q7K) in Complex with Atazanavir |
Heteromer P03367; | 98.99 | 1×CL; 1×DR7; | |||
| X-ray crystal structure of bPI-11 hiv-1 protease complex | homo-2-mer | 94.95 | 3×GOL; 2×SO4; 1×B0F; 1×CL; | |||
| HIV-1 protease (D25N, inactive) in complex with phage display optimized substrate SGIFLETS | homo-2-mer | 93.94 | 4×CL; | |||
| HIV-1 wild type protease with GRL-03314A, 6-5-5-ring fused umbrella-like tetrahydropyranofuran as t… | homo-2-mer | 94.95 | 1×GR8; 1×NA; 3×CL; 1×GOL; 2×ACT; | |||
| HIV-1 wild type protease with GRL-03119A, with phenyl-boronic-acid as P2'-ligand and with a hexahyd… | homo-2-mer | 94.95 | 1×B4R; 1×NA; 5×CL; 1×FMT; 1×GOL; | |||
| HIV-1 wild type protease with GRL-03214A, 6-5-5-ring fused umbrella-like tetrahydropyranofuran as t… | homo-2-mer | 94.95 | 1×NA; 2×CL; 2×GOL; 1×GR5; 1×ACT; | |||
| HIV-1 wild type protease with GRL-00819A, with phenyl-boronic-acid as P2'-ligand and with a 6-5-5-r… | homo-2-mer | 94.95 | 1×NA; 4×CL; 1×FMT; 1×GOL; 1×Q1D; | |||
| P1' Extended HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-State Mimi… | homo-2-mer | 100 | 1×4AH; | |||
| Room Temperature X-Ray Structure of HIV-1 Protease in Complex with Inhibitor GRL-075-24A | homo-2-mer | 94.95 | 1×A1CAJ; | |||
| P1' Extended HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-State Mimi… | homo-2-mer | 100 | 1×2AH; | |||
| Stereoselective Synthesis, X-ray Analysis, and Biological Evaluation of a New Class of Lactam Based… | homo-2-mer | 96.97 | 1×UX9; | |||
| Synthesis and Activity of N-Axyl Azacyclic Urea HIV-1 Protease Inhibitors with High Potency Against… | homo-2-mer | 100 | 1×AAU; | |||
| HIV-1 protease in complex with asymmetric inhibitor, BEA568 | homo-2-mer | 100 | 1×568; | |||
| HIV-1 protease in complex with symmetric inhibitor, BEA450 | homo-2-mer | 100 | 1×BLL; | |||
| VIRACEPT (R) (NELFINAVIR MESYLATE, AG1343): A POTENT ORALLY BIOAVAILABLE INHIBITOR OF HIV-1 PROTEASE | homo-2-mer | 100 | 1×1UN; | |||
| HIV-1 protease in complex with inhibitor AHA455 | homo-2-mer | 100 | 1×A1A; | |||
| P1' Extended HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-State Mimi… | homo-2-mer | 100 | 1×1AH; | |||
| ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESU… | homo-2-mer | 100 | 1×L75; | |||
| Crystal structure of HIV-1 protease complexed with Lopinavir. | homo-2-mer | 100 | 1×AB1; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1k6t.1.A | homo-2-mer | 0.84 | 93.94 | |||